Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fa-Chyi Lee

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Clinical Colorectal Cancer|July 21, 2010
Development of bronchiolitis obliterans organizing pneumonia with platinum-based chemotherapy for metastatic rectal cancerM Houman Fekrazad, Steve Eberhardt, Dennie V Jones, et al.
SAGE Open Medical Case Reports|January 8, 2024
A case report of challenges in distinguishing gastroesophageal junction hepatoid adenocarcinoma from testicular germ cell tumor: Insights for improved diagnosis with gene expression profilingOmid Yazdanpanah, Fa-Chyi Lee, Roozbeh Houshyar, et al.
Frontiers in Oncology|December 14, 2023
Case Report: A complete pathologic response in pancreatic cancer with squamous cell differentiationChristopher R Grant, Zhaohui L Arter, Tran Truc, et al.
The Oncologist|July 9, 2017
Phase II Trial of Sorafenib in Combination with Capecitabine in Patients with Hepatocellular Carcinoma: INST 08-20Yehuda Patt, Cristhiam Rojas-Hernandez, Houman Mohammad Fekrazad, et al.
Melanoma Research|December 21, 2010
Phase I dose finding study of carboplatin, paclitaxel, and temozolomide in advanced solid tumorsSujana Movva, Claire F Verschraegen, Ian Rabinowitz, et al.
Idrugs : the Investigational Drugs Journal|August 31, 2004
TLK-286Claire F Verschraegen, Harriet O Smith, Fa Chyi Lee, et al.
The Oncologist|June 1, 2024
A phase II study of cabozantinib and pembrolizumab in advanced gastric/gastroesophageal adenocarcinomas resistant or refractory to immune checkpoint inhibitorsFarshid Dayyani, Joseph Chao, Fa-Chyi Lee, et al.
American Journal of Clinical Oncology|November 4, 2009
A phase I study of flavopiridol in combination with gemcitabine and irinotecan in patients with metastatic cancerHouman M Fekrazad, Claire F Verschraegen, Melanie Royce, et al.
Journal of Neuro-Oncology|March 31, 2010
Primary disseminated central neurocytoma: cytological and MRI evidence of tumor spread prior to surgeryHoan Tran, Rafael Medina-Flores, Lisa A Cerilli, et al.
Urologic Oncology|March 28, 2008
Phase II studies of antiangiogenic four drug regimens for the treatment of advanced renal cell carcinoma: FUNIL-retinoid and the FUNIL-thalidomide protocolsAlonso V Pacheco, Kanwaldeep Rasila, Sang-Joon Lee, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Clinical Colorectal Cancer|July 21, 2010
Development of bronchiolitis obliterans organizing pneumonia with platinum-based chemotherapy for metastatic rectal cancerM Houman Fekrazad, Steve Eberhardt, Dennie V Jones, et al.
SAGE Open Medical Case Reports|January 8, 2024
A case report of challenges in distinguishing gastroesophageal junction hepatoid adenocarcinoma from testicular germ cell tumor: Insights for improved diagnosis with gene expression profilingOmid Yazdanpanah, Fa-Chyi Lee, Roozbeh Houshyar, et al.
Frontiers in Oncology|December 14, 2023
Case Report: A complete pathologic response in pancreatic cancer with squamous cell differentiationChristopher R Grant, Zhaohui L Arter, Tran Truc, et al.
The Oncologist|July 9, 2017
Phase II Trial of Sorafenib in Combination with Capecitabine in Patients with Hepatocellular Carcinoma: INST 08-20Yehuda Patt, Cristhiam Rojas-Hernandez, Houman Mohammad Fekrazad, et al.
Melanoma Research|December 21, 2010
Phase I dose finding study of carboplatin, paclitaxel, and temozolomide in advanced solid tumorsSujana Movva, Claire F Verschraegen, Ian Rabinowitz, et al.
Idrugs : the Investigational Drugs Journal|August 31, 2004
TLK-286Claire F Verschraegen, Harriet O Smith, Fa Chyi Lee, et al.
The Oncologist|June 1, 2024
A phase II study of cabozantinib and pembrolizumab in advanced gastric/gastroesophageal adenocarcinomas resistant or refractory to immune checkpoint inhibitorsFarshid Dayyani, Joseph Chao, Fa-Chyi Lee, et al.
American Journal of Clinical Oncology|November 4, 2009
A phase I study of flavopiridol in combination with gemcitabine and irinotecan in patients with metastatic cancerHouman M Fekrazad, Claire F Verschraegen, Melanie Royce, et al.
Journal of Neuro-Oncology|March 31, 2010
Primary disseminated central neurocytoma: cytological and MRI evidence of tumor spread prior to surgeryHoan Tran, Rafael Medina-Flores, Lisa A Cerilli, et al.
Urologic Oncology|March 28, 2008
Phase II studies of antiangiogenic four drug regimens for the treatment of advanced renal cell carcinoma: FUNIL-retinoid and the FUNIL-thalidomide protocolsAlonso V Pacheco, Kanwaldeep Rasila, Sang-Joon Lee, et al.
Pageof 4